TM4SF1 was shown to be a partner of DVL2 that positively modulates Wnt/β-catenin signaling by enhancing DVL2-Axin interaction in HCC (Zhu C. et al., 2019). The gene discussed is DVL2; the disease is hepatocellular carcinoma.